OROPIVALONE BACITRACINA 1.5mg / 200UI suction tablets medication leaflet

R02AB04 thixocortol + zinc bacitracin • Respiratory system | Throat preparations | Antibiotics

This combination of tixocortol and bacitracin zinc is used for the treatment of minor skin infections accompanied by inflammation. Tixocortol is a corticosteroid that reduces inflammation, while bacitracin zinc is an antibiotic that prevents bacterial growth.

The medication is available in the form of creams or ointments and should be applied locally as directed by a doctor. The dosage and duration of treatment are adjusted based on the severity of the infection and the patient's response.

Patients should avoid prolonged use of the medication to prevent side effects such as skin thinning or bacterial resistance. It is important to follow the doctor's instructions and avoid contact with the eyes.

Side effects may include local irritation, dryness, or allergic reactions. In rare cases, severe reactions such as hypersensitivity may occur. Patients should inform their doctor of any unusual symptoms.

General data about OROPIVALONE BACITRACINA 1.5mg / 200UI

Substance: thixocortol + zinc bacitracin

Date of last drug list: 01-07-2013

Commercial code: W42606001

Concentration: 1.5mg / 200UI

Pharmaceutical form: suction tablets

Quantity: 40

Product type: original

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Other substances similar to thixocortol + zinc bacitracin